Anxiety Related to the Diagnosis of Alzheimer's Disease or Related Diseases
Anxiety Related to the Diagnosis of Alzheimer's Disease or Related Diseases
Improving the diagnosis of neurocognitive disorders is a major public health challenge. This
 diagnosis occurs too late in the majority of cases, or is even sometimes non-existent for
 some despite the presence of clinical signs and symptoms. However, the etiological diagnosis
 of a TNC is crucial for the patient and his family to understand the most appropriate
 decisions for the future, to plan the organization of his life as long as he is able to do
 so, to access the clinical research, to promote dialogue between patients and their
 caregivers. On the contrary, a late diagnosis may be responsible for the fact that the
 patient and his / her family are less able to benefit from certain psychosocial
 interventions, services and treatments.

 But the diagnostic announcement is retained. One of the negative and dreaded effects of such
 an announcement is the negative psychological impact. Some studies show that the diagnostic
 announcement would worsen the level of anxiety or depressed mood and the risk of social
 isolation. On the other hand, other studies show that symptoms such as anxiety, psychic
 distress and depression remain stable, or even decrease slightly after the announcement of
 the diagnosis, in patients and their relatives. However, the literature is questionable
 because the majority of the studies are retrospective, mono-centric, and the patient numbers
 are low. While the first reactions of patients may be negative after the announcement, some
 report resignation experiences, or form of relief, because they have finally found a clinical
 explanation for the symptoms encountered. While doubt or diagnostic uncertainty, as well as
 the feeling of not knowing the truth, seem to have a more damaging psychological impact on
 the patient and those around him, increasing anxiety and confusion.

 The primary objective is to study if the level of anxiety 2 months after the announcement of
 the diagnosis of Alzheimer's disease or a related disease is not superior to the level of
 anxiety before the announcement with patient / caregiver.

 This present study aim to explore the feasibility with 14 patients.
Improving the diagnosis of neurocognitive disorders is a major public health challenge. This
 diagnosis occurs too late in the majority of cases, or is even sometimes non-existent for
 some despite the presence of clinical signs and symptoms. However, the etiological diagnosis
 of a TNC is crucial for the patient and his family to understand the most appropriate
 decisions for the future, to plan the organization of his life as long as he is able to do
 so, to access the clinical research, to promote dialogue between patients and their
 caregivers. On the contrary, a late diagnosis may be responsible for the fact that the
 patient and his / her family are less able to benefit from certain psychosocial
 interventions, services and treatments.

 But the diagnostic announcement is retained. One of the negative and dreaded effects of such
 an announcement is the negative psychological impact. Some studies show that the diagnostic
 announcement would worsen the level of anxiety or depressed mood and the risk of social
 isolation. On the other hand, other studies show that symptoms such as anxiety, psychic
 distress and depression remain stable, or even decrease slightly after the announcement of
 the diagnosis, in patients and their relatives. However, the literature is questionable
 because the majority of the studies are retrospective, mono-centric, and the patient numbers
 are low. While the first reactions of patients may be negative after the announcement, some
 report resignation experiences, or form of relief, because they have finally found a clinical
 explanation for the symptoms encountered. While doubt or diagnostic uncertainty, as well as
 the feeling of not knowing the truth, seem to have a more damaging psychological impact on
 the patient and those around him, increasing anxiety and confusion.

 The primary objective is to study if the level of anxiety 2 months after the announcement of
 the diagnosis of Alzheimer's disease or a related disease is not superior to the level of
 anxiety before the announcement with patient / caregiver.

 This present study aim to explore the feasibility with 14 patients.
Inclusion Criteria:

 -  Patients :

 -  Man or woman 55 years and over

 -  Patient received for the first time in Memory Consultation and not aware of his
 diagnosis

 -  Patient with a Mini-Mental State Assessment score (MMSE) ≥ 20

 -  Patient accompanied by a primary caregiver

 -  Patient able to provide consent to participate in research

 Caregiver:

 -  The caregiver accompanies the patient and is considered as the main caregiver during
 the consultation

 -  is able to provide consent to participate in research

 Exclusion Criteria:

 -  Patient living in a care homes

 -  Patient protected by law (under legal protection, guardianship or trusteeship)

 -  Patient with a hearing or visual impairment that does not allow to carry out
 assessments in Memory Consultation

 -  Patient opposing research